Chapter 15: Cell Signaling & Signal Transduction

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today we are jumping into a, well, a monumental topic.

The hidden conversation that's happening inside and between every single cell in your body.

That's right.

We're doing a deep dive into the really complex world of cell signaling and signal transduction.

And we're drawing all our insights from the fantastic analysis in Carp's Chapter 15.

Our mission here is to basically walk you through the core machinery of cellular communication step by step to serve as your knowledge shortcut.

Exactly.

We'll be breaking down the receptors, the secondary molecules, the massive cascades, and all the landmark experiments that revealed how cells coordinate everything from, you know, growth to death.

And we're not easing into this at all.

We're starting with one of the most surprising examples of this cellular conversation in the entire natural world.

The Hawaiian bobtail squid.

Oh, it's a fantastic illustration of why single cells even need to talk to each other.

I think it's just amazing.

So picture this.

You have this small nocturnal squid, and it's hovering over the shallow ocean floor, trying to hunt under the moonlight to hide its own shadow from predators that might be lurking below.

It uses something called counter illumination.

It actually produces light on its underside to match the moonlight shining down from above.

But the squid itself isn't what's glowing.

No, not at all.

It's essentially a biological flashlight, and it's powered by symbionts, these massive colonies of bacteria called olivibrio fishery.

And they live inside a specialized light organ in the squid.

Right.

And what's truly remarkable here is that the bacteria only turn on their light, they only bio luminous, when their population density hits a certain critical threshold inside that organ.

And that's a perfect tangible example of what's called quorum sensing.

It is essentially these little single celled organisms are using chemical messages to gauge the size of the crowd.

They're basically thinking, OK, there are enough of us here now to actually make a difference.

So let's all coordinate and turn on the lights.

And even at this, you know, really basic bacterial level, we can see two fundamentally different signaling strategies at play.

We do.

In gram positive bacteria, they typically secrete these short modified peptides.

These peptides build up in the environment.

And when the concentration gets high enough, they bind to receptors that are located right on the cell surface.

And that kicks off the response.

But the gram negative bacteria, like the ones in our squid friend, they use a different trick.

A totally different trick.

They release these small molecules,

specifically AHL or non -isole homocerein lactones.

And because these molecules are tiny and non -polar, they just diffuse freely right across the bacterial cell membrane.

So they don't need a receptor on the outside.

Exactly.

Once they're inside, they bind directly to cytoplasmic transcription factors, changing gene expression, and ultimately turning on the light.

So whether it's peptides or small lipids, the fundamental process is really the same.

Chemical messages are being used to coordinate a collective action.

And that brings us to the big picture, you know, why this chapter is so foundational for understanding complex life.

Right.

In a multicellular organism, like a human, cells just cannot operate in isolation.

No, they have to coordinate everything.

Whether they're responding to a threat, deciding to divide, or moving toward a food source.

Cell signaling is what makes the right

environmental or internal stimuli even possible.

It affects basically every aspect of cell function and structure, from motility to metabolism.

And this regulation is just.

It's absolutely critical.

Because if those intricate controls over cell growth and division are lost, if the signaling goes haywire, we are looking straight at malignancy and the development of cancer.

So understanding these communication pathways is really understanding the potential vulnerabilities in disease.

Okay,

let's unpack the basic geography of communication then.

First off, how far does the message travel?

We can categorize this into three main modes of signaling.

Right.

Starting really local, we have autocrane signaling.

You can think of this as a sort of cellular self -talk.

Yeah.

A cell produces a messenger,

it expresses receptors for that same messenger on its own surface, and then it stimulates or inhibits itself.

This happens a lot in tumor cells that secrete their own growth factors to fuel their proliferation.

Okay, so that's local.

Then we scale up just a little bit to paracrine signaling.

Right.

This is short -distance communication.

Messengers travel through the extracellular space, but only to their immediate neighbors.

And why is the distance limited?

Well, the travel distance is strictly limited because these messenger molecules are usually pretty unstable.

They degrade quickly or they just get stuck.

They bind tightly to the extracellular matrix, which prevents them diffusing too far.

Got it.

And finally, for the really long -haul messages, we have endocrine signaling.

Exactly.

Here, the messengers, which we call hormones, are stable enough to travel throughout the entire body using the bloodstream.

So they leave an endocrine gland, like the pancreas, and can reach target cells anywhere.

That's right.

Coordinating these huge, large -scale systemic responses, like regulating your blood sugar.

So now we get to the core mechanism, the overall signal transduction pathway.

We can think about this process as a chain of, what, nine sequential steps that translate an external chemical event into an internal actionable response.

That's a great way to put it.

And the pathway kicks off with the release of the extracellular messenger.

These ligands can be anything from tiny steroids to gases like NO or even large protein hormones like glucagon.

And next is that critical recognition phase, receptor binding.

A cell will only respond to message if it has a specific high -affinity receptor that recognizes that ligand.

And this is a really important insight here.

The cellular response isn't just determined by the message itself.

It's determined by the pre -existing internal machinery that the cell already has.

So give us an example of that.

Okay, take adrenaline.

It binds to the beta -2 adrenergic receptor.

If that happens in a liver cell, the internal machinery is all set up to break down glycogen for energy.

Right.

But if the exact same event, same receptor, same stimulus happens in a smooth muscle cell that's lining a blood vessel, the result is relaxation.

Wow.

So same signal, but a radically different outcome just depending on the cell type.

Exactly.

The cell is pre -wired for a specific response.

Okay.

So once the ligand is bound, the third step happens.

This binding causes a conformational change in the receptor.

Yes, a shape change.

This acts like a toggle switch, and it relays the signal from the extracellular domain right across the membrane to the receptor's cytoplasmic domain.

The message has now officially crossed the barrier.

And from this point, the mechanism splits into two major routes depending on what kind of receptor it is.

That's right.

Route A is primarily used by what are called G -protein coupled receptors, or GPCRs.

In this route, the activated receptor physically engages a nearby enzyme, which we call the effector protein.

The effector then catalyzes the production of a huge number of second messenger molecules.

And a second messenger is what exactly?

It's a small non -protein molecule like Campy or TextiP33 or calcium ions.

Because they're small, they can rapidly diffuse through the cytosol or stay embedded in the membrane.

They act as these rapid mobile amplifiers, activating or inactivating specific target proteins inside the cell.

Okay.

So that's route A.

What about route B?

Route B is typical of receptor tyrosine or RTKs.

This route does not rely on a diffusable second messenger.

So what does it do?

Instead, the receptor's own cytoplasmic domain becomes a sort of high traffic recruiting station.

It attracts and organizes all these different cellular signaling proteins using specialized interaction domains.

Okay.

So regardless of the route, the signal then leads to the activation of a protein at the very top of an intracellular signaling pathway.

Which then kicks off a sequential series of distinct proteins operating one after the other.

But it's really important to visualize these not as neat linear tracks.

It's more like a complex dynamic and interconnected web.

And how do these proteins talk to each other down the cascade?

What's the language they're using?

The primary language of signal transduction is the addition or removal of phosphate groups.

This chemical modification alters the shape and therefore the activity of the next protein in line.

And this phosphorylation system is

it's massive.

Oh, it's huge.

The human genome encodes over 500 different protein kinases.

Those are the ones that add phosphates and about 150 different protein phosphatases, which remove them.

And most of these kinases are focused on adding phosphates to

serine or 309 residues.

Right.

But there's a highly important minority about 90 kinases that specifically target tyrosine residues.

And the placement of a phosphate on a tyrosine residue is often the signature of a growth factor signal.

It's a really important distinction.

So what can phosphorylation actually do to a protein?

The effects are incredibly diverse.

It might activate one enzyme or inactivate another.

It can change protein binding affinity, trigger the movement of a protein to a new location, or even mark the protein for degradation.

It's a very versatile switch.

And we can see the dramatic consequences of this system failing when we look at, say, cancer.

Absolutely.

The text has this really stark analysis comparing different types of breast cancer cells in the triple negative breast cancer cells, which are notoriously aggressive because they lack the receptors for standard therapy.

Right.

They exhibit a much, much greater frequency of tyrosine phosphorylation compared to other cell lines.

So that excessive level of on signaling suggests a failure to turn the signal off.

Precisely.

And research correlates this observation with the potential loss of a specific protein tyrosine phosphatase, PTP and 12 in those aggressive cells.

So the protein that's supposed to remove the phosphate, the off switch, is missing.

Right.

So the PTAR signal just persists and persists, driving uncontrolled growth and malignancy.

So the signals travel down the cascade, they reach their final target proteins, and that generates the cellular response, a change in gene expression or metabolism or movement.

And finally, the signal has to be terminated.

Termination is just as crucial as activation because it ensures the cell stays sensitive to the next message.

How does that happen?

A couple of ways.

You can have enzymatic destruction of the extracellular messenger itself, or a process called desensitization, which often involves pulling the activated receptor inside the cell and either degrading it or recycling it for later.

Okay.

Let's shift our focus to the messengers themselves.

These extracellular carriers of information fall into what, five general categories?

That's right.

We start with amino acids and their derivatives.

This includes neurotransmitters like glutamate and hormones like epinephrine and thyroid hormone.

Then you have the simple gases.

Yeah, like nitric oxide, NO, and carbon monoxide, CO.

They're unique because they can just diffuse right through the plasma membrane to signal internally.

Third are the steroids, which are nonpolar lipids derived from cholesterol.

And because they're lipid soluble, they can also pass directly through the cell membrane, which allows them to regulate things like sexual differentiation and metabolism from inside the cell.

Fourth, the icosinoids.

These are derived from 20 carbon fatty acids like arachidonic acid.

And they are vital local regulators of pain, inflammation, and blood clotting.

And it's a key clinical connection here that many common over -the -counter anti -inflammatory drugs work by directly inhibiting the synthesis of these very messenger.

And finally, the broadest category, polypeptides and proteins.

Right.

This is everything from growth factors to differentiation factors and the large glycoproteins that are involved in the immune response.

It's a huge group.

So these diverse messengers are received by one of four main classes of receptors.

And these receptors define how the cell internally processes the message.

First up, we have the G protein coupled receptors, GPCRs.

They're defined by their unique structure, seven transmembrane alpha helices.

And their function is always to activate an intermediary GTP binding protein, or G protein.

Second, the receptor protein tyrosine kinases, RTKs.

These are single -pass membrane proteins.

They generally dimerize when a ligand binds, which activates an intrinsic kinase domain that phosphorylates tyrosine residues inside the cell.

Third are the ligand -gated channels.

These are essential for rapid signaling, especially in the nervous system.

The receptor is an ion channel.

And when the ligand binds, the channel opens directly.

Ions flow across the membrane, generating an electric signal very fast.

And fourth, the steroid hormone receptors.

Right.

Since they're messengers, steroids can cross the membrane.

These receptors are located intracellulately, either in the cytosol or the nucleus.

They function as ligand -regulated transcription factors, directly changing gene expression when the hormone binds.

So we're going to concentrate now on GPCRs, which are, I mean, statistically speaking, the most important class.

They make up the single largest superfamily of proteins encoded by animal genomes.

The scope is just staggering.

GPCRs mediate your ability to see photons, to smell odorants, and to taste sweet, bitter, and umami.

They regulate hormones, neurotransmitters, cellular communication across almost all physiological systems.

Looking at their structure, you can visualize those seven alpha helices threading back and forth across the membrane.

Right.

With the N -terminus outside, the C -terminus inside.

The ligand binds in a pocket formed by the extracellular loops.

And the cytoplasmic loops are what interface with the G protein.

The classic structural example for a GPCR is rhodopsin, the visual pigment in your rod cells.

That's right.

In the dark, rhodopsin is stable.

But when it absorbs a photon of light, its retinal cofactor isomerizes, it literally flips its chemical structure.

And this subtle chemical flip has a major physical consequence.

A huge one.

It disrupts a stabilizing ionic linkage deep inside the receptor, which leads to a crucial conformational change, an outward tilt and rotation of the sixth transmembrane helix.

And that tilt is the signal being relayed.

That's it.

It exposes a specific binding site for the G protein, which in this case is called transducin.

Okay, let's walk through the full crucial G protein signal transduction cycle.

This mechanism is really the definition of signal amplification and regulation over time.

So the process starts when the ligand binds to the receptor, causing that necessary shape change.

This immediately increases the receptor's affinity for the inactive heterotrimeric G protein.

And that's composed of the alpha, beta, and gamma subunits, all tethered to the inner surface of the membrane.

Exactly.

The receptor G protein interaction then forces the G alpha subunit to release its bound GDP.

A GTP molecule from the cytosol then rushes in and takes its place.

And that GTP binding is the moment of activation.

It is.

And here is where the amplification starts.

A single active receptor can go on to activate dozens of G protein molecules.

Okay, so once GTP is bound, the G alpha GTP subunit physically dissociates from the G beta gamma complex.

And now G alpha GDP is free to bind to and activate an effector protein, like adenyl cyclase.

But importantly, the G beta gamma dimer is also active, and it can go off and signal on its own, sometimes opening or closing ion channels.

The activated effector then produces a massive wave of the second messenger, for example, CMP.

Which rapidly spreads the signal throughout the entire cell.

Now we get to the most vital piece of internal regulation,

the shutdown mechanism.

Yes.

The G alpha subunit has an intrinsic built -in GTP activity.

It slowly hydrolyzes the bound GTP back to GDP, plus an inorganic phosphate.

So it has its own molecular timer.

It has its own molecular timer.

Once that GTP is cleaved to GDP, the G alpha subunit changes conformation again, inactivating itself.

And finally, the inactive G alpha GDP lets go of the effector, and re -associates with the G beta gamma complex, reforming the inactive hetero trimer.

And the system is reset, which ensures that the signal is always brief and proportional to the original stimulus.

Now this GPCR system is diversified by the different flavors of the G alpha subunits, right?

They act as distinct switches based on which effector they target.

Exactly.

You have any allers, which is stimulatory, it couples receptors to and activates adenyl cyclase, which raises KMP levels.

Then there's G allers, which activates an enzyme called phospholipase C beta.

And on the other side.

On the inhibitory side, you have G dollars, which does the opposite of DG dollars.

It inhibits adenyl cyclase, lowering CMP levels.

And then we have the less studied G1213 family, which has been linked to driving excessive cell proliferation and malignancy when it's inappropriately activated.

You know, the discovery of G proteins is one of the great historical sagas of cell biology.

It started with Earl Sutherland in the 1950s, who established the foundational concept.

Right.

That hormones bind a surface receptor, which activates adenyl cyclase inside, which generates KMP.

But how the signal actually crossed the membrane was a total mystery.

The key experimental work came from Martin Rod Bell and Lutz Bernbommer, who are studying isolated plasma membranes.

They call them fat cell ghosts.

Yeah.

And they were testing multiple hormones like ACTH, epinephrine, glucagon, that all seem to generate TMP.

And they asked a really clever question.

Do these hormones stimulate separate populations of adenyl cyclase?

And their tests show that when they mix the hormones, the resulting KMP generation was not additive.

Which was the first critical clue.

If three different hormones stimulate the same maximum amount of KMP, they must all be working on the same population of adenyl cyclase.

So the receptor and the effector must be separate components linked by some unknown intermediary.

Exactly.

Then Rod Bell's team published a series of papers in 1971 detailing the role of guanine nucleotides.

They were tracking how labeled glucagon bound to liver membranes.

And they found something strange.

They did.

They found that GTP at tiny concentrations caused the rapid dissociation of the labeled glucagon from the membrane.

That's revolutionary.

It implied that guanine nucleotides must somehow be physically changing the receptor's conformation on the inside, which then decreases its affinity for the ligand on the outside.

Right.

And furthermore, they show that GTP was absolutely required for adenyl cyclase activity, even at its baseline.

The definitive proof of the mechanism came from using these non -hydrolyzable GTP analogs like GPP and HP.

Yes.

These analogs mimicked GTP's ability to activate the enzyme.

But because they couldn't be cleaved, the adenyl cyclase activity was prolonged indefinitely.

Which proved that GTP binding activates the enzyme, but GTP hydrolysis terminates it.

And that insight immediately led Don Castle and Zvi Selinger to look for the hydrolysis mechanism.

They measured GTPase activity in the membranes and found that the presence of a hormone actually stimulated the GTPase.

Which confirmed the whole loop.

Activation leads to a signal, which then triggers the intrinsic molecular timer to shut itself off.

And this research had immediate clinical applications through the analysis of cholera toxin.

Right.

Castle and Selinger showed that the toxin works by targeting the G protein and inhibiting its GTPase activity.

If the timer is broken and the G alpha subunit can't turn itself off, adenyl cyclase stays perpetually stimulated.

Leading to the massive life -threatening fluid secretion you see in cholera.

Exactly.

And the final confirmation came in 1980 when Alfred Gilman's team successfully purified the GTP binding protein itself.

They isolated the whole heterotrimeric complex, the alpha, beta, and gamma subunits.

And Gilman proved that the alpha subunit contained the GTP binding site and that the activation process required the physical dissociation of the G protein subunits before the alpha unit could interact with the effector.

His work really solidified the functional model we use to this day.

So turning back to the living cell,

rapid signal termination or desensitization is essential to prevent overstimulation.

This happens in two key phases.

Right.

First, the cytoplasmic tail of the activated GPCR gets phosphorylated by a

family called the G protein -coupled receptor kinases, GRKs.

And they specifically recognize the active ligand -bound confirmation of the GPCR.

That's right.

And second, that phosphorylation creates a binding site for proteins called arrestins.

Arrestins.

Arrestins bind to the receptor and physically compete with the G proteins, which prevents the receptor from coupling to any more G proteins.

It effectively shuts down the communication stream.

But arrestins are more than just blockers.

They're protein hubs.

They are.

They promote the receptor's internalization, often recruiting the machinery for endocytosis via clathrin -coated pits.

And once it's internalized, the receptor has several possible fates.

It could be degraded in lysosomes, leading to a temporary loss of sensitivity.

Right.

Or it could be dephosphorylated and return to the plasma membrane in a process called resensitization, which allows the cell to become sensitive to the signal again quickly.

And there's a surprising third possibility, which is that the receptor, still bound to arrestin, forms signaling endosomes.

Yeah, this is fascinating.

Arrestins act as scaffolds inside these endosomes, recruiting and activating entire pathways like the MAP kinase cascade, proving that cell signaling is not just restricted to the plasma membrane.

And for the G alpha subunit itself, that molecular timer, its intrinsic GT -PACE activity, is not fast enough on its own.

No, it's accelerated significantly by specialized enzymes called regulators of G protein signaling, RGSs, which ensures a really rapid and tight shutdown.

We mentioned cholera toxin targeting the G alpha GT -PACE.

There's also Purchases toxin, which causes whooping cough.

Right.

That toxin inactivates Galfa subunits, which interferes with the signaling cascade that hosts use to defend against pathogens.

These toxins really highlight the central role G proteins play in host -pathogen interactions.

So finally, let's explore the human perspective on GPCRs.

Given their huge numbers, it's inevitable that defects lead to a whole bunch of diseases.

Oh, absolutely.

We see clear examples of loss of function defects.

Retinitis pigmentosa, or RP, which causes progressive blindness, is often caused by rhodopsin mutations.

And that causes the receptor to misfold or just be unable to efficiently activate the G protein transducin.

Right, which prevents the necessary signal cascade for vision.

And on the opposite end, you have gain -of -function mutations, which lead to constitutive activity.

Meaning the receptor is always signaling, even without its ligand.

Exactly.

A prime example is found in benign thyroid tumors, or adenomas.

A mutation in the TSH receptor causes it to constitutively activate its G protein.

Which leads to excessive thyroid hormone secretion and uncontrolled cell proliferation, completely independent of stimulation by the actual pituitary hormone.

And because this mutation only occurs in the tumor tissue, it's a somatic mutation, not an inherited one.

We also see the herpes virus that's responsible for Kaposi's sarcoma, encoding its own constitutively active GPCR that mimics the action of interleukin 8, driving proliferation signals.

And sometimes the defect is just weird and complex.

There's a G alpha isoform mutation that causes contrasting effects based on temperature.

It's active at the lower temperature of the testes, leading to premature puberty.

But inactive at the core body temperature of the parathyroid glands, leading to hypoparathyroidism.

That's just incredible.

It shows the incredible subtlety and sensitivity of the system.

And it's also vital to remember that genetic polymorphisms, the common variations in our DNA, can influence GPCR function.

So variations in the beta -2 adrenergic receptor are linked to differences in susceptibility of asthma or high blood pressure.

And polymorphism in the CCR5 receptor strongly affects susceptibility and progression of HIV.

Okay, now let's delve into the molecules that enable that amplification we talked about, the second messengers.

And synchemP, cyclic AMP, is the historical standard bearer.

It is.

SynchemMP is synthesized by adenyl cyclase, which is an integral membrane protein.

And because kinkMP is small and water soluble, it can diffuse widely through the cytosol, quickly translating a localized receptor event into a massive, coordinated response across the entire cell.

And the key effector of kinkMP is protein kinase A, or pKa.

Right.

pKa is generally held in an inactive state by its regulatory subunits.

When CNP concentrations rise, CNP binds to those regulatory subunits, causing them to dissociate.

Which releases the active catalytic subunits of pKa, and they then go on to phosphorylate their target proteins.

And the signal must be terminated rapidly.

That job falls to camP -phosphadesterase, which hydrolyzes camP, breaking it down and restoring the basal state.

Next, we have messengers derived from phosphadilinositol lipids that were once thought to be just structural.

Yeah, but they're converted into potent signaling molecules called phosphinositides by specific lipid kinases.

So the inositol ring of these phospholipids, which is on the cytoplasmic surface, can be phosphorylated at positions 3, 4, or 5.

Exactly.

For example, PI3 kinase, or PI3K, can phosphorylate TEXPI, $4 .5 TEXP2 -unfree, or just TEXPI -P3.

And the creation of these distinct phosphinositides is critical because they generate binding sites on the inner surface of the membrane.

Right.

Specific protein domains, called pH domains, recognize and bind to these phosphorylated lipids, which effectively recruits their associated protein to the plasma membrane.

We can visualize this effect in migrating cells during chemotaxis.

Yeah, it's a great example.

When a cell is moving toward an attractant, TEXP33 production is heavily localized to the leading edge of the cell.

And that's where it recruits the necessary proteins to drive the formation of actin filaments and propel the cell forward.

The lipid itself is dictating the direction of movement.

It is.

Now let's look at the mechanism that generates some of the most famous second messengers.

The activation of phospholipase C, PLC.

So when a ligand activates a G -Qual coupled receptor, the G -Qual protein activates PLC -β.

And PLC -β acts like a pair of molecular scissors.

It cleaves the membrane -bound TEXPI -4 .5 -2 into completely different but equally important second messengers.

The first product is diacylglycerol,

DAG, a lipid that stays anchored in the plasma membrane.

And DAG recruits and activates protein kinase C, PKC.

PKC is a major serine threonine kinase involved in regulating cellular growth, differentiation, and metabolism.

The role of PKC in growth control is dramatically illustrated by a class of compounds called four -ball esters.

Oh yeah.

These plant compounds are potent mimics of DIGE.

And when you introduce them to cells, they trigger this temporary malignant behavior, a loss of growth control, which really demonstrates PKC's pivotal role in proliferation signals.

So that's one product.

The second product is inositol, $1 ,4004 -phosphate -tex -tiennitri.

Right.

And unlike DIGE, TEXTIP3 is a small water -soluble sugar phosphate that rapidly diffuses into the cytosol, seeking its target.

Which is the TEXTIP3 receptor, a calcium channel embedded in the membrane of the smooth endoplasmic reticulum.

Exactly.

TEXTIP3 binding opens this channel, causing a sudden massive release of stored calcium ions into the cytosol, making calcium itself the next highly potent second messenger.

And this calcium release doesn't always result in just one sustained surge.

No.

Researchers observing liver cells responding to the visopressin hormone found they exhibit these periodic calcium oscillations.

So the amplitude of the calcium spike stays fixed, but as the hormone concentration rises, the frequency of the spikes increases.

It's amazing.

It demonstrates that cells use frequency modulation, not just concentration, to encode information.

So let's look at how these systems converge in a crucial physiological process.

The regulation of blood glucose.

Right.

Glucagon and epinephrine adrenaline both act via GPCRs, and they both instruct liver cells to do the exact same thing.

Break down glycogen and inhibit its synthesis.

So glucagon binds its receptor, activating G to fallers.

Epinephrine binds the adrenergic receptor, also activating G to fallers.

Which means you have two different ligands and two different receptors converging onto the same C.

diadenly cyclis C.

MMP pathway.

And that results in the identical physiological output of glucose mobilization.

And this glucose mobilization cascade is a textbook example of signal amplification.

Let's trace PKA's actions here.

Okay.

So once the PKA catalytic subunits are active, they execute two complementary actions.

First, they phosphorylate and inhibit glycogen synthase, which immediately stops the cell from storing any more glucose.

And second.

Second, PKA activates phosphorylase cranius.

Phosphorylase kinase is now active, and in turn, it activates glycogen phosphorylase, which is the enzyme that actually breaks down glycogen into glucose -1 -phosphate.

The amplification is just incredible.

One hormone molecule leads to many G proteins, many CAMPs, many PKAs.

Which ultimately leads to the mobilization of a truly massive number of glucose molecules from storage.

It is an exponential explosion of activity.

And the signal also has long -term consequences.

It does.

Activated PKA subunits can translocate right into the nucleus, where they phosphorylate the transcription factor CRE.

And phosphorylated CRE binds to a specific DNA sequence called the CRE, CARE -AP response element, and activates genes required for long -term glucose production.

Right.

So the short -term metabolic effect is backed up by a long -term change in gene expression.

But this universality leads to the ultimate question of specificity.

If CAMP and PKA are everywhere, mediating such diverse functions, how does the cell know which function to execute?

That is the key question.

And this is where AKA PKA anchoring proteins become essential.

They are sophisticated non -enzymatic scaffolds.

So what do they do?

AKA physically sequester PKA to specific subcellular locations.

The plasma membrane, the nucleus, the cytoskeleton placing PKA in close physical proximity only to its relevant substrate proteins in that area.

So even though PKA is activated cell -wide, it only phosphorylates the appropriate targets in a specific microdomain.

Spatial localization is the key.

That is the key to ensuring signaling specificity and avoiding chaotic crosstalk.

We can't conclude GPCRs without recognizing their profound role in sensory perception.

Absolutely not.

Vision, as we noted, involves rhodopsin activating the G protein transducin, which activates an enzyme that breaks down CGMP.

And what's unusual is that in the dark, high CGMP keeps sodium channels open.

So the signal is generated not by opening channels, but by the reduction of CGMP, which closes the channels.

Right.

And smell relies on hundreds of different odor and receptor GPCRs.

The ligand activates the receptor, leading to a massive surge of CAMP -P synthesis, which then opens a specialized CAMP -P gated cation channel, triggering a nerve impulse.

And taste relies on GPCRs for three of the five basic flavors.

Bitter, sweet, and umami.

Right.

Bitter tastes, sensed by T2Rs, are an evolutionary defense against toxins.

Sweet and umami signal energy or protein sources.

And these GPCRs activate G proteins that use PLC beta to generate IP3 and calcium signals.

Okay.

Before we dive into RTKs, the field of biosensors shows how we can hijack these signaling principles for engineering.

I mean, your blood glucose meter uses an enzyme, glucose oxidase, to generate a conductive product.

Exactly.

And we can adapt to GPCRs for molecular biosensors inside the cell.

One method uses for a T, or fluorescence resonance energy transfer.

How does that work?

You engineer the receptor with two fluorescent tags that are close together.

When the receptor is activated and changes shape, the distance between the tags shifts, and that changes the fluorescent signal, reporting the activation in real time.

And there's another powerful biosensor system.

Yeah.

This one involves attaching a transcription factor to the GPCR tail via a cleavage domain.

A protease, fused to beta -restin, only becomes active when the GPCR is ligand -bound.

So the protease cleaves the transcription factor.

Which then moves to the nucleus to turn on a reporter gene, like a fluorescent protein, giving you a long -term visual readout of receptor activity.

It's really clever stuff.

So shifting now to protein tyrosine phosphorylation, this whole regulatory mechanism seemed to have emerged around the time of multicellularity.

It did.

It provides the rapid, targeted communication that's essential for coordinating growth.

And it's regulated by receptor tyrosine kinases, RTKs, which are integral membrane proteins, and non -receptor tyrosine kinases, which are in the cytoplasm.

And RTKs respond to crucial growth factors.

So it's no surprise that unregulated, constitutively active RTKs are among the most important drivers of uncontrolled cell division in cancer.

Absolutely.

And the first defining step in RTK activation is receptor dimerization.

The two separate receptor monomers have to be brought together to activate the kinase domain.

And we see two main ways this happens.

There's ligand -mediated dimerization.

Right, where the ligand itself is bivalent.

It has two parts, and it acts like a bridge, physically connecting two receptor monomers together.

PDGF works this way.

And then there's receptor -mediated dimerization.

In this case, a monovalent ligand, like epidermal growth factor EGF, binds.

This binding causes a crucial conformational change in the receptor that exposes or creates a physical dimerization interface, allowing the two ligand -bound monomers to interact side by side.

So once the dimer forms,

the cytoplasmic kinase domains are brought close together.

Which allows for trans -autophosphorylation.

One receptor subunit phosphorylates tyrosine residues on the cytoplasmic domain of the other subunit.

And this autophosphorylation serves two vital purposes.

Right.

First, it regulates the enzyme's activity by moving the activation loop out of the active site.

And second, it creates this massive array of specific high -affinity docking sites for downstream signaling proteins.

And these docking sites rely on specialized domains that recognize phosphorylated tyrosine residues, or P -tier.

The most widespread is the SH2 domain.

There are over 110 of these in the human genome.

An SH2 domain binds specifically not just to the P -tier residue, but also to the 3 -5 adjacent amino acids.

The sequence context is everything.

It's everything.

One SH2 domain might recognize P -tier met X -met, while another recognizes P -tier glu -isle, ensuring highly specific protein recruitment.

The second domain is the PTB domain.

Right, the phosphotyrosine binding domain.

While many PTBs also bind P -tier, they often recognize slightly different motifs, typically involving as pro -X -tyre.

So the signaling proteins that are recruited to the active RTK fall into three functional groups.

Group 1 are the adapter and scaffolding proteins.

These just act as organizational linkers.

The key example is Group B.

And Group 2 has one SH2 domain to dock onto the P -tier site on the RTK, and two SH3 domains that constitutively bind to partners like SOs.

Exactly.

Its job is purely to link the receptor to the next functional step.

Group 2 are transcription factors, notably the STAT family.

STATs have SH2 domains.

They get recruited to the activated RTK, their phosphorylated ontyrosine residues, and then they dimerize.

The P -tier on one STAT binds the SH2 domain of its partner.

And this dimer then moves to the nucleus to directly activate gene transcription.

And Group 3 are the signaling enzymes themselves.

Kinases, phosphopases, GIPs, all equipped with SH2 domains.

They are activated upon recruitment either by moving close to their substrates or by direct phosphorylation from the RTK itself.

Termination of the RTK signal is primarily achieved through receptor internalization, usually via clathrin -mediated endocytosis.

And a key regulatory step here is ubiquitination, often mediated by c -bialidases, which marks the receptor for internalization and eventual degradation in the lysosome.

This brings us to the centerpiece of RTK signaling, the Ras -Met kinase pathway.

This pathway is just ubiquitous and essential for growth and proliferation.

It is.

Ras is a small monomeric G protein anchored to the membrane.

And like the G alpha subunit, it's a binary switch, active when GDP bound, inactive when GDP bound.

And it also acts as a timer, relying on GTP hydrolysis to tune itself off.

And this is a pathway of massive clinical relevance.

Oh, huge.

Tumor -causing mutations in Ras are incredibly common.

They often prevent the protein from hydrolyzing GTP, which locks Ras permanently in the on position.

Driving relentless uncontrolled proliferation, and it's implicated in what, about 30 % of human cancers?

Something like that.

And the cycling of Ras is tightly controlled by three classes of accessory proteins.

You have GEFs, or guanine nucleotide exchange factors, like SOSOS.

They promote activation by forcing GDP to be released so GDP can bind.

Then you have GAPs, GDPase -activating proteins.

Right.

They accelerate the intrinsic GDPase activity of Ras, effectively acting as the shutdown mechanism.

Defects in Ras gaps, like mutations in the NF1 gene, lead to prolonged Ras activity and cause neurofibromatosis.

And finally, GDIs, or dissociation inhibitors.

Which prevent the release of GDP, keeping Ras inactive until the proper signal arrives.

Okay, let's trace the full essential MbA kinase cascade.

First, the activated RTK recruits the GORITUSOS adapter complex.

Right, bringing the GEFsOS to the membrane, which then activates Ras.

Activated RasGTP then recruits and activates the protein kinase RAF, which is the first member of the cascade, sometimes called MPKK.

RAV then phosphorylates and activates the next kinase, MEK, or MACEK.

MEK is a unique dual specificity kinase, meaning it can phosphorylate both tyrosine and serine threonine residues.

And MEK then activates the final kinase, ERK, or MAPP kinase, by phosphorylating its TRX -tyre sequence.

And this three -tiered phosphorylation scheme, MPKK to MPEK to MAPPK, is the universal signature of this entire signaling family.

Activated MAPK then moves into the nucleus, where it phosphorylates various transcription factors, like ELK1.

Which increases their affinity for DNA regulatory sites, driving the expression of growth -related genes like FOS, Jun, and cyclin D1.

And termination, again, is built right in.

It is.

MAPK activity itself drives the transcription of a specific phosphatase, MKP1.

MKP1 then moves back into the nucleus to remove the activating phosphates from MAPK, shutting down the entire cascade and resetting the proliferation signal.

But the complexity here is that this core kinase trio is used for dozens of different cellular responses, growth, stress response, differentiation.

How is specificity maintained?

The answer is scaffolding proteins.

These proteins physically tether the appropriate members of a pathway together, preventing them from interacting with components of parallel pathways.

Like in yeast, the MBKK's D11 is part of two different pathways.

Exactly.

When it's recruited by the St5 scaffold, it drives the mating response.

But when it's recruited by the PBS2 scaffold, it drives the osmoregulatory response.

Same kinase, different context.

In a famous experiment, it created a chimeric protein where the mating factor receptor was linked to the osmoregulatory scaffold.

And when mating factor was introduced, the cells displayed the osmoregulatory response, proving definitively that the scaffold structure, not the initial receptor, determines the pathway outcome and maintains specificity.

That's a profound insight.

Location and organization dictate function.

It really is.

Let's examine the insulin receptor signaling pathway, a major RTK pathway with some unique architectural elements.

It's very unique.

Unlike most RTKs that are monomers until they're activated, the insulin receptor is a stable alpha -2 -beta -2 dimer linked by disulfide bonds even when it's inactive.

And insulin binding, even a single molecule,

causes a structural repositioning of the extracellular domains, which brings the cytoplasmic beta chains close together.

And this juxtaposition triggers the trans -autophosphorylation of the beta chains, activating the receptor's tyrosine kinase domain.

What's distinct here is the use of IRS proteins, or insulin receptor substrates.

Right.

Instead of recruiting signaling proteins directly to its own phosphorylation sites, the insulin receptor recruits a family of large docking proteins, the IRS proteins, via their PTB domain.

And this is a vital mechanism for amplification and integration.

It is.

The receptor then phosphorylates numerous tyrosine residues on the IRS protein, and this single massive IRS molecule then acts as an

multivalent docking station, recruiting many different SH2 -containing proteins simultaneously, GERB2, SHHP2, and most critically, PI3K.

The recruitment activates PI3K, which then phosphorylates membrane lipids, specifically converting PIP2 into the key messenger PIP3.

And PIP3 then acts as the anchor, recruiting two pH domain -containing kinases, PDK1 and PKB, also known as AKT, to the inner membrane surface.

And PKB is activated by phosphorylation from PDK1 and MTOR.

PKB is the critical hub for insulin survival and metabolic signals.

Termination of this crucial pathway is performed by the lipid phosphatase, PTN.

PTN removes the phosphate from the 3 -position of the inositol ring, reverting PIP3 back to PIP2, effectively erasing the signal.

And PTN is often mutated or lost in cancer, which leads to constantly active PKB, driving proliferation.

Exactly.

And PKB, or AKT, mediates the primary physiological responses to insulin.

First, glucose transport.

In muscle and fat cells, PKB triggers the translocation of GLUT4 glucose transporters from storage vesicles to fuse with the plasma membrane.

Which massively increases glucose uptake from the bloodstream.

And second, glytogen synthesis.

PKB does this by phosphorylating and inactivating GSK3.

Since GSK3 normally inhibits glycogen synthase, inactivating it removes the breaks, leading to increased glycogen synthase activity and promoting storage.

And the failure of this precise signaling chain is the biological basis of type 2 diabetes mellitus.

That's right.

Chronic high calorie diets and sedentary lifestyles lead to chronic high insulin secretion, which causes target cells to become insulin resistant.

The cells just stop responding to the hormone, breaking this critical feedback loop and leading to chronically elevated blood Moving far from animal metabolism, we look at auxin signaling IAA, the master regulator of plant gene expression.

So, auxin regulates transcription by influencing the degradation of repressor proteins.

In low auxin conditions, ARF transcription factors are bound and repressed by OxyA repressor proteins.

But when auxin levels are high, auxin acts as a sort of molecular glue or adapter.

It does.

It binds simultaneously to the OxyA and an E3 ubiquitin -litus.

This action targets the OxyA repressor for ubiquitination and rapid degradation, thereby freeing the ARF transcription factors to activate the genes needed for growth.

While this transcriptional regulation takes time, evidence suggests auxin also induces a rapid response within seconds.

Right, possibly mediated by the ABF1 receptor.

The precise molecular mechanism for this fast response remains a really intriguing open question in plant biology.

Finally, let's look closer at calcium as an intracellular messenger.

It's involved in everything from fertilization to neurotransmission.

And cytosol at calcium has to be maintained at extremely low basal levels, roughly 10 to the minus 7 molar, which is about 10 ,000 times lower than outside the cell or inside the ER.

And this tight control is maintained by energy -driven calcium pumps and exchangers that are constantly pushing the ions out of the cytosol.

Right.

And signaling rapidly elevates calcium concentration by opening channels, either IP3 -gated channels on the SER or voltage -gated calcium channels in the plasma membrane.

Researchers used sophisticated fluorescent probes like FUR2 to visualize calcium dynamics.

And this revealed that calcium release is often highly localized, like in a small part of a neuron's dendrite following synaptic activation, rather than immediately sweeping the whole cell.

The SER also has another critical channel type, the ryanodyne receptor, or RIRR.

RIRRs are crucial in muscle cells, where a small influx of calcium from the outside causes the RIRRs to open, triggering a massive release of stored calcium, a process called calcium -induced calcium release, or CICR.

And that's what drives contraction.

Exactly.

And sometimes the release propagates as a full calcium wave throughout the entire cell.

The most visually dramatic example is the wave that sweeps through an egg immediately after fertilization by a sperm, which is the trigger for the egg to begin mitotic division.

Cells also have a mechanism to replenish depleted stores, called SOCE, or store -operated calcium entry.

This involves physical communication between the ER and the plasma membrane.

When ER calcium stores are low, the calcium -sensing protein STIM1 clusters within the ER membrane.

STIM1 then physically recruits and interacts with array 1, the calcium channel in the adjacent plasma membrane.

And that interaction opens array 1, allowing external calcium influx to rapidly refill the ER stores.

Calcium doesn't typically act directly, though.

It needs intermediary proteins.

The universal example is chalmodulin.

Right.

Chalmodulin contains four calcium binding sites.

When cytosolic calcium levels rise, the binding changes chalmodulin's conformation, transforming it into this general purpose regulatory molecule that's capable of interacting with dozens of different effectors.

For instance, calcium chalmodulin activates cam and Ks, chalmodulin -dependent protein kinases, which can phosphorylate CRE on the exact same serine 133 residue that's targeted by PKA.

Which means signals generated by GPCRs using calcium can converge on the same nuclear transcription factor as signals using cam and K.

And in the plant world, calcium regulates water conservation in guard cells, which control the stomated diameter.

That's right.

The stress hormone, abscisic acid, binds its receptor, which opens calcium channels.

The resulting elevated cytosolic calcium acts as a signal that closes potassium influx channels while simultaneously opening potassium and anion efflux channels.

This massive ion outflow causes water to leave the cell osmotically.

The guard cell deflates, and the stomata close to conserve water.

Okay, we've discussed so many linear pathways, but the cellular reality is a massively interconnected web characterized by convergence, divergence, and crosstalk.

Convergence means signals from unrelated receptors can activate a single common effector.

Right.

So for example, growth factors via RTKs, hormones via GPCRs, and even cell matrix interactions via integrins can all converge to activate RAS and the downstream MAP kinase cascade.

Divergence is what we saw with insulin or epinephrine.

A single ligand activates multiple different pathways at the same time.

Resulting in a complex set of coordinated responses like protein synthesis, glucose uptake, and cell survival, all triggered by one hormone.

And crosstalk occurs when pathways directly intersect.

A classic example is the relationship between the PKA and MAP kinase pathways.

Right.

PKA, activated by KMP, can actually inhibit the MAP kinase cascade by phosphorylating and inhibiting the RAF protein.

Conversely, the MAP kinase cascade, when it's activated, can activate its own kinase that then phosphorylates CREA, the same nuclear target of PKA.

This incredible complexity means the cell's final response is not a simple sum, but a really precise calculation based on the balance of all these inputs.

Which raises a fundamental challenge for researchers.

Specificity.

If PI3K is activated by both insulin and the growth factor EGF, and both signals promote cell survival, how do they produce such distinct outcomes?

And the answer is likely in the details.

Different isoforms of PI3K are different downstream targets being organized and sequestered by specific scaffolding proteins that are present in that unique cellular context.

The context is the message.

Next, we look at the simple inorganic gas messenger, nitric oxide, NO.

NO is unique because it is both a short -range extracellular messenger and an intracellular second messenger.

The discovery, which earned the Nobel Prize, started with Robert Furchgott finding that acetylcholine only induced smooth muscle relaxation if endothelial cells were present.

He realized the endothelium was releasing an intermediary factor, which was later identified as NO.

So the signaling pathway is clear.

Acetylcholine binds the endothelial receptor, raising calcium, which activates nitric oxide synthase, NOS.

NO is synthesized from L -arginine and immediately diffuses into the adjacent smooth muscle cell.

Once inside, NO stimulates soluble guanulocyclis, leading to a massive surge in the second messenger, CGMP.

And CGMP then activates CGMP -dependent protein kinase, leading to smooth muscle relaxation and vasodilation.

Which explains the clinical action of nitroglycerin used for chest pain.

It's metabolized into NO, which causes vasodilation.

And this pathway is famously exploited by drugs like Viagra.

Right.

Sildenafil doesn't affect NO production itself, but it inhibits the enzyme CGMP phosphodesterase, which normally breaks down CGMP.

So by inhibiting the breakdown, the drug prolongs the half -life of CGMP, thereby extending smooth muscle relaxation and erection maintenance.

Finally, we have to discuss one of the most fundamental processes regulated by cell signaling,

apoptosis or programmed cell death.

Apoptosis is the need orderly process where a cell shrinks, its contents are packaged into small apoptotic bodies, and it's rapidly engulfed by phagocytes.

And this is strictly controlled and prevents the inflammatory mess of necrosis, where the cell swells and ruptures.

Exactly.

Apoptosis is essential for biological housekeeping, sculpting tissues during embryonic development like separating your fingers, eliminating dangerous T -cells, and clearing irreparably damaged or unneeded cells.

The numbers are just staggering.

We estimate 10 to 100 billion cells die this way every day in an adult human.

And the central executioners of apoptosis are caspases.

They're cysteine proteases that are synthesized as inactive procaspases.

Once they're activated, caspases cleave hundreds of critical proteins.

Like protein kinases, which shuts off survival signals, lamins, which causes nuclear fragmentation, and an endonuclease that degrades DNA.

And apoptosis is activated by two main routes.

The extrinsic pathway is receptor -mediated, triggered by external death messengers like TNF or tumor necrosis factor.

TNF binds its trimeric death receptor, which exposes cytoplasmic death domains.

This leads to the assembly of a complex that recruits and activates two molecules of procaspase VIII.

An activated caspase VIII is the initiator caspase, which then signals to the executioner caspases.

The intrinsic pathway is mitochondria -mediated, triggered by internal stress signals like DNA damage or hypoxia.

This pathway is controlled by the BCL2 protein family.

Right.

The family includes pro -apoptotic members like Bax and Box, and anti -apoptotic members like BCL2 and BCLXL.

When internal stress occurs, pro -apoptotic members like Bax and Box, oligomerase, and the outer mitochondrial membrane forming large channels.

And this channel formation releases mitochondrial proteins into the cytosol, most notably cytochrome C, which is the point of no return.

Cytochrome C then forms a massive wheel -shaped structure called the apoptosome, with APAF1 and procaspase IX.

Procaspase IX is activated, initiating the final executioner cascade.

But if caspase VIII is somehow blocked, the cell can still die via necroptosis, a regulated inflammatory death.

Right.

This involves the formation of a necrosome, which ultimately activates the MLKL protein, causing the plasma membrane to rupture.

So the fate of the cell's survival or death is dependent on the delicate balance of these signals.

It is.

For instance, TNF signaling, which initiates apoptosis, also often transmits a strong survival signal via the transcription factor NF -kB.

The cell's ultimate outcome is the sum of these competing signaling outputs.

What an incredible exhaustive look at the complex molecular language that governs life.

We've seen that the cell is constantly engaged in a conversation that defines its entire existence.

We have.

We've confirmed that fundamental distinction between the 7 TM GPCRs, which rely on the molecular timer of the G protein and the rapid diffusion of second messengers for amplification, and the single pass RTKs, which rely on dimerization and localized scaffolding to build massive signaling platforms.

The necessity of molecules like CAMPY, IP3, DIGI, and calcium for coordinated amplified responses just cannot be overstated.

And the regulatory complexity introduced by convergence, divergence, and crosstalk, all governed by organization via scaffolding proteins like AKPs and arrestins, really demonstrates why failures in this system drive pathology.

From diabetes to aggressive cancers.

So we leave you with this final provocative thought.

Given the sheer overlap in these growth pathways, how rest of EPK is shared across virtually all survival and proliferation signals, and given the many therapies target receptor activity broadly.

How might a future therapeutic drug be engineered to specifically target a scaffolding protein to derail a malignant signal without shutting down every other vital interconnected pathway in the cell?

The future of precision medicine might just lie in regulating location, not just activity.

That challenge finding specificity in a converging system is truly the next frontier.

Thank you for joining us on this deep dive into cellular conversations.

From the last minute lecture team, we hope this comprehensive summary provides the foundation you need to conquer this challenging material.

Keep learning and we'll catch you on the next deep dive.